Company intelligence / Profile preview

Spectranetics

Colorado Springs, Colorado, United Statesspectranetics.com ↗

Ownership: Private
Employees: ~900
Development stage: Other

Overview

Spectranetics developed and commercialized a portfolio of medical devices for vascular intervention—including laser atherectomy catheters for treating coronary and peripheral artery disease as well as the Stellarex drug-coated balloon. The company’s products were supported by robust clinical evidence and had obtained regulatory approvals in the US (FDA PMA) and Europe (CE mark). At the time of acquisition by Philips in 2017, sales were growing at double-digit rates with projected 2017 revenue around $300 million[1][5].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Spectranetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spectranetics.

Explore the full profile